Power Law company profile

Jounce Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2013 · IPO 2017 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue

$82M

Latest reported FY

Investors

10 investors on Jounce Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Series B+ 9 investors entered at this stage

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo